Drugmaker Pfizer Inc. said Tuesday that early results from a late-stage study of its pain treatment Lyrica showed that it did better than a placebo in reducing one type of pain after a spinal cord injury.
Popular Posts:
- Roche says skin cancer drug substantially shrinks
- Roche says skin cancer drug substantially shrinks
- Roche says skin cancer drug substantially shrinks
- Roche says skin cancer drug substantially shrinks
- FDA delays decision on lupus drug Benlysta